Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: A psychostimulant theory of antidepressant sleep deprivation

Psychopharmacology

Volumn 140, Issue 1, 1998, Pages 1-10

  Ebert, Dieter ^a   Berger, Mathias ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Depression; Dopamine; Psychostimulant; Sleep deprivation; Therapy

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; NORADRENALIN; PSYCHOSTIMULANT AGENT; SEROTONIN;

BRAIN METABOLISM; CATECHOLAMINE RELEASE; DEPRESSION; DOPAMINERGIC SYSTEM; GENE EXPRESSION; HUMAN; LIMBIC SYSTEM; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; POSTSYNAPTIC INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REVIEW; SLEEP DEPRIVATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DOPAMINE; HUMANS; LIMBIC SYSTEM; NEUROTRANSMITTER AGENTS; SLEEP DEPRIVATION;

EID: 0031787390     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050732     Document Type: Review

References (98)

1. Abercrombie ED, Zigmond MJ (1995) Modification of central catecholaminergic systems by stress and injury. Functional significance and clinical implications. In: Bloom F, Kupfer DJ, Psychopharmacology. Raven Press, New York, pp 355-361
2. Asakura W, Matsumoto K, Ohta H, Watanabe H (1994a) Monoamine depletion attenuates the REM sleep deprivation-induced increase in clonidine response in the forced swimming test. Pharmacol Biochem Behav 49:79-84
3. 2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacol Biochem Behav 48:43-46
4. Asikainen M, Deboer T, Porkka-Heiskanen T, Stenberg D, Tobler I (1995) Sleep deprivation increases brain serotonin turnover in the Djungarian hamster. Neurosci Lett 198:21-24
5. Asikainen M, Toppila J, Alanko L, Ward DJ, Stenberg D, Porkka-Heiskanen T (1997) Sleep deprivation increases brain serotonin turnover in the rat. Neuroreport 8: 1577-1582
6. Ayd FJ, Zohar J (1987) Psychostimulant therapy for chronic and treatment-resistant depression. In: Zohar J, Belmaker M (eds) Treating resistant depression. PMA, New York, pp 343-355
7. Beckmann H, van Kammen DP, Goodwin FK, Murphy DL (1976) Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithium. Biol Psychiatry 11:377-387
8. Benedetti F, Barbini B, Campori E, Colombo C, Smeraldi E (1996) Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res 65:179-184
9. Bertolucci PH, Andrade LA, Lima JG, Carlini EA (1987) Total sleep deprivation and Parkinson disease. Arq Neuropsiquiatr 45:224-230
10. Bradberry CW (1994) Microdialysis assessment of the impact of 3,4-methylamphetamine, cocaine, and cocaethylene on serotonergic neurons. Drug Dev Res 33:1-9
11. Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, Selbie S, Belenky G, Herscovitch P (1997) Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 120:1173-1197
12. 2 receptor binding in the rat frontal cortex. Pharmacol Biochem Behav 52:43-48
13. Broekkamp C, Berendsen H (1996) Role of dopamine-serotonin interrelationships in psychotropic drug effects. In: Beninger R, Palomo T, Archer T (eds) Dopamine disease states. CYM, Madrid, pp 251-262
14. Clark C, Dupont R, Golshan J, Gillin C (1997) HMPAO SPECT, polysomnography, and antidepressant response to partial sleep deprivation. Sleep Res 26:247
15. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104:177-180
16. 1 receptor antagonist binding in the rat limbic system. Neurosci Lett 117:224-227
17. Devous MD, Trivedi MH, Gong W, Harris TS, Rush AJ (1995) RCBF changes in limbic and limbically innervated brain regions in normal controls following oral amphetamine challenge. J Cereb Blood Flow 15:S829
18. 2 receptors in depression measured with SPECT. Biol Psychiatry 35: 128-132
19. Drevets WC, Botteron K (1997) Neuroimaging in psychiatry. In: Guze SB (ed) Adult psychiatry. Mosby, St Louis, Mo.
20. Drevets WC, Raichle ME (1997) Functional anatomical correlates of unipolar versus bipolar depression. Biol Psychiatry 42:217S
21. Ebert D, Ebmeier K (1996) The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry. Biol Psychiatry 39:1044-1050
22. Eben D, Kaschka W (1995) Humorale Aspekte des Schlafentzuges. Fortschr Neurol Psychiatr 63:441-450
23. Ebert D, Feistel H, Barocka A (1991) Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc99 m HMPAO SPECT. Psychiatry Res Neuroimaging 40:247-251
24. Ebert D, Kaschka WP, Stegbauer P, Schrell U (1993) Prolactin response to sulpiride in depression before and after sleep deprivation. Biol Psychiatry 35:880-885
25. Ebert D, Feistel H, Barocka A, Kaschka WP (1994a) Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res Neuroimaging 55: 101-109
26. 2 receptor blockade in depression before and after sleep deprivation. Biol Psychiatry 35:880-885
27. Ebert D, Albert R, Hammond R, Strasser G, May A, Merz A (1996a) Eye blink rates and depression is the antidepressant effect of sleep deprivation mediated by the dopamine system? Neuropsychopharmacology 15:332-339
28. Ebert D, Feistel H, Loew T, Pirner A (1996b) Dopamine and depression dopamine receptor SPECT before and after antidepressant therapy. Psychopharmacology 126:91-94
29. Ebmeier KP, Ebert D (1996) Imaging functional change and dopaminergic activity in depression. In: Beninger R, Palomo T, Archer T (eds) Dopamine disease states. CYM, Madrid, pp 511-522
30. Ebmeier KP, Cavanagh J, Moffoot AP, Glabus MF, O'Carroll RE, Goodwin GM (1997) Cerebral perfusion correlates of depressed mood. Br J Psychiatry 170:77-81
31. Ernst M, Zametkin A, Matochik J, Schmidt M, Jons P, Liebenauer L, Hardy K, Cohen R (1997) Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 17:391-401
32. Essman WD, Singh A, Lucki I (1994) Serotonergic properties of cocaine. Pharmacol Biochem Behav 49:107-113
33. 1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem Int 20:153S-156S
34. Farooqui SM, Brock JW, Zhou J (1996) Changes in monoamines and their metabolite concentrations in REM sleep-deprived rat forebrain nuclei. Pharmacol Biochem Behav 54:385-391
35. Fratta W, Collu M, Martellotta MC, Pichiri M, Muntoni F, Gessa G (1987) Stress-induced insomnia: opioid-dopamine interactions. Eur J Pharmacol 142:437-440
36. Gehde E, Emrich HM (1996) Systemtheoretische Konzepte zur Wirkung des Schlafentzuges. In: Kasper S, Möller HJ (eds) Therapeutischer Schlafentzug. Springer, Wien, pp 229-263
37. Gerner RH, Post RM, Bunney WE (1976) A dopaminergic mechanism in mania. Am J Psychiatry 133:1177-1180
38. Gessa G, Pani L, Serra G, Fratta W (1995) Animal models of mania. In: Gessa G, Fratta W, Pani L, Serra G (eds) Depression and mania from neurobiology to treatment. Raven Press, New York, pp 43-66
39. Grasby PM, Friston KJ, Bench CJ, Cowen PJ, Frith CD, Liddle PF, Frackowiak RSJ, Dolan RJ (1993) The effect of the dopamine agonist apomorphine on regional cerebral blood flow in normal volunteers. Psychol Med 23:605-612
40. Haug H, Gschwind M, Naber G, Hobi V (1997) Sleep deprivation in schizophrenic patients with negative symptoms. Eur Neuropsychopharmacol 7 [Suppl 2]:S203
41. Ho AP, Gillin JC, Buchsbaum MS, Wu JC, Abel L, Bunney WE (1997) Brain glucose metabolism during NREM sleep in major depression. Arch Gen Psychiatry 53:645-652
42. Hooks MS, Jones DN, Justice JB Jr, Holtzman SG (1992) Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav 42: 765-770
43. Inoue T, Koyama T (1996) Effects of acute and chronic administration of corticosterone and dexamethasone on regional brain dopamine and serotonine metabolism in rats. Prog Neuropsychopharmacol Biol Psychiatry 20:147-156
44. Johanson C, Schuster C (1995) Cocaine. In: Bloom F, Kupfer DJ, Psychopharmacology. Raven Press, New York, pp 1685-1697
45. Jones DN, Holtzman SG (1992) Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J Pharmacol Exp Ther 262: 638-645
46. Kahn DA, Prohovnik I, Lucas LR, Sackheim HA (1989) Dissociated effects of amphetamine on arousal and cortical blood flow in humans. Biol Psychiatry 25:755-767
47. Kapur S, Meyer J, Houle S, Brown G (1994) Functional anatomy of the dopaminergic system: PET study in humans. Neuropsychopharmacology 10:17S
48. Katz RJ, Roth KA, Schmaltz K (1981) Amphetamine and tranylcypromine in an animal model of depression: pharmacological specificity of the reversal effect. Neurosci Biobehav Rev 5: 59-64
49. Koob GF, Parsons LH, Caine SB, Weiss F, Sokoloff P, Schwartz JC (1996) Dopamine receptor subtype profiles in cocaine reward. In: Beninger RJ (ed) Dopamine disease states. Editorial CYM, Madrid
50. Kuczenski R, Segal DS (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065
51. Kuhs H, Tölle R (1991): Sleep deprivation therapy. Biol Psychiatry 29:1129-1148
52. Lammers CH, Diaz G, Levesque D, Griffon N, Schwartz JC, Sokoloff P (1995) Regulation of dopaminergic receptor mRNA by antidepressants. Pharmacopsychiatry 28:196
53. 2 receptors in striatum and anterior cingulate in depression. Neuroimage 5:251-260
54. Laruelle E (1995) SPECT imaging of striatal dopamine release after amphetamine. J Nuc Med 36:1182-1190
55. Lauterbach EC (1994) Sleep benefits and SD in subgroups of depressed patients with Parkinson disease. Am J Psychiatry 151: 782-783
56. Loh EA, Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101: 262-266
57. Maj J (1990) Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system. In: Gessa G. Serra G (eds) Dopamine and mental depression. Pergamon Press, Oxford, pp 139-146
58. Mannelli M, Delitalia G, DeFeo LM, Maggi M, Cuomo S, Piazzini M, Guazelli R, Serio M McCann UD, Penetar DM, Shaham Y. Thorne TR, Gillin JC, Sing HC, Thomas ML, Belenky G (1992) Sleep deprivation and impaired cognition. Biol Psychiatry 31:1082-1097
59. Markou A, Kosten T, Koob GF (1998) Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18:135-174
60. Marinelli M, Oliveira C, Moal M, Piazza P (1997) Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. Neuropsychopharmacology 16:156-161
61. Mathew RJ, Wilson WH (1985) Dextroamphetamine-induced changes in regional cerebral blood flow. Psychopharmacology 87:298-302
62. Matussek N, Ackenheil M, Athen D, Beckmann H, Benkert O, Dittmer T, Hippius H, Loosen P, Rüther E, Scheller M (1974) Catecholamine metabolism under sleep deprivation therapy of improved and not-improved depressed patients. Pharmacopsychiatry 7:114-198
63. McCann UD, Penetar DM, Shaham Y, Thorne TR, Sing HC, Thomas ML, Gillin JC, Belenky G (1993) Effects of catecholamine depletion on alertness and mood in rested and sleep deprived volunteers. Neuropsychopharmacology 8: 345-356
64. Müller H, Riemann D, Berger M, Müller W (1993) The influence of TSD on urinary excretion of catecholamine metabolites. Acta Psychiatr Scand 88:16-20
65. 2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res Bull 34:453-460
66. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 112:110-114
67. Parkes JD (1983) Variability in Parkinson's disease. Acta Neurol Scand 95:27-35
68. Patchev V, Felszeghy K, Koranyi L (1991) Neuroendocrine and neurochemical consequences of long term sleep deprivation in rats: similarities to some features of depression. Homeostasis 33:97-108
69. Pflug B, Tölle R (1971) Therapie endogener Depressionen durch Schlafentzug. Nervenarzt 42:117-124
70. Post RM, Weiss SRB (1992) Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol Psychiatry 32:469-484
71. Potkin SG, Buchsbaum M, Yin J, Wu J, Coster J, Gulasekaram G, Richmond G, Fallon J, Hong C, Telford J, Sittangan K (1994) Brain metabolic correlates of antipsychotic response. Neuropsychopharmacology 10:696S
72. Prevot E, Maudhuit C, Poul E, Hamon M, Adrien J (1996) SD reduces the citalopram-induced inhibition of serotonergic firing in the nucleus raphe dorsalis of the rat. J Sleep Res 5:238-245
73. Przeulocki R (1984) Some aspects of physiology and pharmacology of endogenous opioid peptides. Pol J Pharmacol Pharm 36:137-158
74. Reist C, Sokolski RN, Chen CC, Coskinas E, Dement EM (1995) The effect of sleep deprivation on motor impairment and retinal adaptation in Parkinson s disease. Prog Neuropsychopharmacol Biol Psychiatry 19:445-454
75. Sachar EJ, Asnis G, Nathan RS, Halbreich U, Tabrizi MA, Halpern FS (1980) Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed. Arch Gen Psychiatry 37:755-757
76. Salomon R, Delgado P, Licinio J, Krystal J, Heninger G, Charney D (1994) Effects of sleep deprivation on serotonin function in depression. Biol Psychiatry 36:840-846
77. Schreiber W, Opper C, Dickhaus B, Heiser P, Krieg J, Wesemann W (1995) Effects of total sleep deprivation on serotonergic transmission in humans. Pharmacopsychiatry 28:214
78. Schulte W (1966) Kombinierte Psycho- und Pharmakotherapie bei Melancholikern. In: Kranz HN (ed) Probleme der pharmakopsychiatrischen Kombinationsbehandlung. Karger, Basel, pp 150-169
79. Seifritz E, Müller M, Annen O, Nil R, Hatzinger M, Hemmeter U. Moore P, Holsboer E (1997) Effects of SD on neuroendocrine response to a serotonergic probe in healthy male subjects. J Psychiatr Res 31:543-554
80. Seltzer V, Tonge SR (1975) Proceedings methylamphetamine withdrawal as a model for the depressive state: antagonism of post-amphetamine depression by imipramine. J Pharm Pharmacol 27 [Suppl 2]: 16P
81. 2 binding in depression. Psychol Med 131:18-26
82. 2-like dopamine receptors. Psychopharmacology 133:77-84
83. Sokolski KN, Reist C, Chen C, DeMet EM (1995) Antidepressant responses and changes in visual adaptation after sleep deprivation. Psychiatry Res 57:197-207
84. Van den Hoofdakker R (1997) Total sleep deprivation. In: Ansseau H, Praag H (eds) Depression: neurobiological, psychopathological and therapeutic advances. Wiley, New York
85. Van Kammen DP, Murphy DL (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215-224
86. Van Kammen DP, Murphy DL (1978) Prediction of imipramine antidepressant response by a one-day dextro-amphetamine trial. Am J Psychiatry 135:1179-1184
87. Van Kammen DP, Boronow JJ (1988) Dextro-amphetamine diminishes negative symptoms in schizophrenia. Int Clin Psychopharmacol 3:111-121
88. Volk S, Kaendler S Weber, R, Georgi K, Maul F, Hertel A, Pflug B (1992) Evaluation of the effects of total sleep deprivation on cerebral blood flow using single photon emission computerized tomography. Acta Psychiatr Scand 86:478-483
89. Volk S, Kaendler S, Weber R, Georgi K, Maul F, Hertel A, Pflug B, Hör G (1997) Can response topartial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow. Psychiatry Res Neuroimaging 75:67-74
90. Volkow N, Wang G, Fowler J, Logan J, Lieberman J, Pappas N (1997) Effects of methylphenidate on regional brain glucose metabolism in humans. Am J Psychiatry 154:50-55
91. Wang GJ, Volkow ND, Fowler JS, Ferrieri R, Schlyer DJ, Alexoff D, Pappas N, Lieberman J, King P, Warner D, Wong C, Hitzemann RJ, Wolf AP (1994) Methylphenidate decrease regional cerbral blood flow in normal human subjects. Life Sci 54:PL143-146
92. Watson R, Hartmann E, Schildkraut JJ (1972) Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry 129:263-269
93. Wehr TA, Sack DA, Rosenthal NE (1987) Sleep reduction as a final common pathway to mania. Am J Psychiatry 144:201-204
94. Willner P (1995) Dopaminergic mechanisms in depression and mania. In: Bloom F, Kupfer DJ (eds) Psychopharmacology. Raven Press, New York, pp 921-932
95. Wu JC, Bunney WE (1990) The biological basis of an antidepressant response to sleep deprivation. Am J Psychiatry 147: 14-21
96. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE (1992) Effects of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149:538-543
97. Wu JC, Gillin JC, Buchsbaum MS, Cadwell S, Lottenberg S, Bunney WE (1994) PET studies of sleep deprivation in unipolar depression. Neuropsychopharmacology 10 [3s]:876S
98. Yoburn BC, Lutfy K, Sierra V (1991) In vitro d-amphetamine and cocaine increase opioid binding in mouse brain homogenate. NIDA Res Monogr 105:522-523